Evidence map›Paper›PMID 26753632›Full record

ArticleEpidemiology and psychiatric sciences2017

Approval of psychotherapy and medication for the treatment of mental disorders over the lifespan. An age period cohort analysis.

S Van der Auwera, G Schomerus, S E Baumeister, H Matschinger, M Angermeyer

Abstract read
In one paragraph

Article in Epidemiology and psychiatric sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S Van der AuweraDepartment of Psychiatry,University Medicine Greifswald,Greifswald,Germany.
G SchomerusDepartment of Psychiatry,University Medicine Greifswald,Greifswald,Germany.
S E BaumeisterInstitute for Epidemiology and Preventive Medicine,University of Regensburg,Regensburg,Germany.
H MatschingerInstitute of Social Medicine,Occupational Health and Public Health,University of Leipzig,Leipzig,Germany.
M AngermeyerDepartment of Public Health,University of Cagliari,Cagliari,Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPrevious cross-sectional studies revealed inconsistent results regarding mental health treatment preferences among the general population. In particular, it is unclear to what extent specific age groups approve psychotherapy or psychotropic medication for the treatment of mental disorders. We explore whether treatment recommendations of either psychotherapy or psychiatric medication change over the lifespan which includes age-related effects due to increasing age of a person, cohort effects that reflect specific opinions during the time a person was born and period effects that reflect societal changes.

methodsUsing data from three identical population surveys in Germany from 1990, 2001 and 2011 (combined n = 9046), we performed age-period-cohort analyses to determine the pure age, birth cohort and time period effects associated with the specific treatment recommendations for a person with either depression or schizophrenia, using logistic Partial Least-Squares regression models.

resultsFor both disorders, approval of both psychotherapy and medication for a person with mental illness increases with age. At the same time, younger cohorts showed stronger recommendations particularly for psychotherapy (OR around 1.07 per decade). The strongest effects could be observed for time period with an increase in recommendation between 1990 and 2001 with odds ratio of 2.36 in depression and 2.97 in schizophrenia, respectively. In general, the treatment option that showed the strongest increase in recommendation was medication for schizophrenia and psychotherapy for depression.

conclusionUnderutilisation of psychotherapy in old age seems not to reflect treatment preferences of older persons. Thus, special treatment approaches need to be offered for this group that seems to be willing for psychotherapy but do not yet use it. Cohort patterns suggest that approval of psychotherapy among older persons will likely further increase in the coming years as these people get older. Finally, strong period effects underpin the importance of changing attitudes in the society. These could reflect reporting changes about psychiatric topics in the media or a general increase in the perception of treatment options. Nevertheless, more treatment offers especially for older people are needed.

Indexed as

AdolescentAdultAgedAge FactorsCohort StudiesCross-Sectional StudiesDepressionFemaleGermanyHumansMiddle AgedPopulation SurveillancePsychotherapyPsychotropic DrugsSchizophreniaSchizophrenic PsychologyPsychotropic DrugsAge-period-cohortpsychotherapy in old age

Identifiers

PMID26753632
PMCPMC6998652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.